Tag Archives: HYH

Top 10 Performing Stocks To Buy For 2019

The Q3 2017 earnings report for large cap consumer electronics retail stock Best Buy Co Inc (NYSE: BBY) is scheduled before the market opens on Thursday (November 17th) as a technical chart shows shares still in an apparent uptrend albeit also appearing to have leveled off or be range bound since mid-August:

A long term performance chart shows shares of Best Buy Co all over the place, Aaron’s, Inc (NYSE: AAN) coming in flat for investors and hhgregg, Inc (NYSE: HGG) severely underperforming:

Top 10 Performing Stocks To Buy For 2019: Daxor Corporation(DXR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Logan Wallace]

    Daxor Co. (NYSEAMERICAN:DXR) saw a significant growth in short interest in the month of March. As of March 29th, there was short interest totalling 234,045 shares, a growth of 1,257.4% from the March 15th total of 17,242 shares. Based on an average daily trading volume, of 1,214,477 shares, the days-to-cover ratio is presently 0.2 days. Currently, 33.3% of the company’s shares are short sold.

Top 10 Performing Stocks To Buy For 2019: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Vanda Pharmaceuticals (VNDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Vanda Pharmaceuticals (VNDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After it was announced yesterday that the stock would be added to the S&P 600 index, shares in Vanda Pharmaceuticals (NASDAQ:VNDA) jumped on Wednesday and were up 10% at 2 p.m. EDT. 

  • [By Stephan Byrd]

    Media stories about Vanda Pharmaceuticals (NASDAQ:VNDA) have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vanda Pharmaceuticals earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave media coverage about the biopharmaceutical company an impact score of 46.3857713397213 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Vanda Pharmaceuticals (VNDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $22.40.

Top 10 Performing Stocks To Buy For 2019: Martin Midstream Partners L.P.(MMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    ONEOK (NYSE:OKE) has made several shrewd moves over the past few years, which have positioned it to grow its high-yielding dividend at a high rate. One of the latest is its recent deal to buy out Martin Midstream Partners’ (NASDAQ:MMLP) 20% interest in the West Texas LPG pipeline system. With full control of that pipeline, the company can more aggressively pursue expansion opportunities, which recently led it to secure a second project on the system that positions it for even more growth in the future.

  • [By Matthew DiLallo]

    Master limited partnerships (MLPs) Buckeye Partners (NYSE:BPL) and Martin Midstream Partners (NASDAQ:MMLP) currently yield a jaw-dropping 13.7% and 17.4%, respectively. Both payouts are well above the 8% average yield of MLPs held in the Alerian MLP Index, which is a clear sign that the market doesn’t believe in the long-term viability of these payouts. Their unsustainability is even more apparent when we look at the embarrassingly weak financial profiles currently backing these payouts, which is why investors should steer clear of these high-yield stocks.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Martin Midstream Partners (MMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Martin Midstream Partners (MMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Buy For 2019: Halyard Health, Inc.(HYH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Halyard Health (NYSE:HYH) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.26.

  • [By Logan Wallace]

    Principal Financial Group Inc. lifted its stake in Halyard Health (NYSE:HYH) by 2.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 232,419 shares of the medical instruments supplier’s stock after purchasing an additional 6,411 shares during the period. Principal Financial Group Inc. owned 0.49% of Halyard Health worth $10,710,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Renaissance Technologies LLC acquired a new position in Halyard Health (NYSE:HYH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 9,805 shares of the medical instruments supplier’s stock, valued at approximately $453,000.

Top 10 Performing Stocks To Buy For 2019: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Chris Lange]

    Juniper Pharmaceuticals Inc. (NASDAQ: JNP) shares rallied early on Tuesday after the company announced that it would be acquired by Catalent. The transaction is expected to close in the third quarter of 2018.

Top 10 Performing Stocks To Buy For 2019: Canadian National Railway Company(CNI)

Advisors’ Opinion:

  • [By Paul Ausick]

    GE got some good news this past week with an order for 200 locomotives from Canadian National Railway Co. (NYSE: CNI). The locomotives will be built at GE’s plant in Fort Worth, Texas, and deliveries to the rail operator will begin next year. The balance of the locomotives will be delivered in 2019 and 2020.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Canadian National Railway (CNI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Neha Chamaria]

    Investing for really long periods of time, however, becomes easier if you bet on industry stalwarts that have consistently rewarded shareholders and possess strong growth catalysts to keep them going for years to come. I can think of four such “forever” stocks right now: Canadian National Railway (NYSE:CNI), Waste Management (NYSE:WM), Mastercard (NYSE:MA), and Visa (NYSE:V).

  • [By Motley Fool Staff]

    In this segment, Brendan Mathews — a member of the Stock Advisor research team, and the portfolio lead for Odyssey 2 and Supernova — talks about the lessons one can learn from the tale of Canadian National (NYSE:CNI), a Stock Advisor recommendation since 2008. One might expect a railroad company to be a steady, predictable performer, but its stock chart looks more like a roller coaster over that period. (And, as a bonus, they also chat a bit about the story of salesforce.com (NYSE:CRM), so stick around to the end.)

Top 10 Performing Stocks To Buy For 2019: Build-A-Bear Workshop, Inc.(BBW)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dollar Tree, Inc. (NASDAQ: DLTR) is expected to report quarterly earnings at $1.23 per share on revenue of $5.56 billion.
    Express, Inc. (NYSE: EXPR) is projected to report quarterly loss at $0.02 per share on revenue of $466.25 million.
    Dollar General Corporation (NYSE: DG) is estimated to report quarterly earnings at $1.4 per share on revenue of $6.20 billion.
    Tech Data Corporation (NASDAQ: TECD) is expected to report quarterly earnings at $1.46 per share on revenue of $8.13 billion.
    Burlington Stores, Inc. (NYSE: BURL) is estimated to report quarterly earnings at $1.09 per share on revenue of $1.49 billion.
    Ciena Corporation (NYSE: CIEN) is projected to report quarterly earnings at $0.3 per share on revenue of $726.56 million.
    American Eagle Outfitters, Inc. (NYSE: AEO) is expected to report quarterly earnings at $0.22 per share on revenue of $806.17 million.
    Titan Machinery Inc. (NASDAQ: TITN) is estimated to report quarterly loss at $0.08 per share on revenue of $276.27 bmillion.
    Donaldson Company, Inc. (NYSE: DCI) is projected to post quarterly earnings at $0.52 per share on revenue of $682.68 million.
    Ship Finance International Limited (NYSE: SFL) is expected to report quarterly earnings at $0.21 per share on revenue of $92.08 million.
    Perry Ellis International, Inc. (NASDAQ: PERY) is projected to report quarterly earnings at $0.67 per share on revenue of $232.30 million.
    Kirkland's, Inc. (NASDAQ: KIRK) is estimated to report quarterly loss at $0.09 per share on revenue of $140.83 million.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) is expected to report quarterly earnings at $0.18 per share on revenue of $90.20 million.
    J.Jill, Inc. (NYSE: JILL) is projected to report quarterly earnings at $0.19 per share on revenue of $160.50 million.
    Christopher & Banks Corporation (NYSE: CBK) is expected to report quarterly loss at $0.08 per share on revenue of $89.35 million.
  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Joseph Griffin]

    News coverage about Build-A-Bear Workshop (NYSE:BBW) has been trending somewhat negative on Thursday, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Build-A-Bear Workshop earned a media sentiment score of -0.07 on Accern’s scale. Accern also assigned media stories about the specialty retailer an impact score of 43.9525750448852 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top 10 Performing Stocks To Buy For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Intesa Sanpaolo (BIT:ISP) received a €2.90 ($3.37) price target from research analysts at Deutsche Bank in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the stock.

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

  • [By Logan Wallace]

    Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.

Top 10 Performing Stocks To Buy For 2019: Rite Aid Corporation(RAD)

Advisors’ Opinion:

  • [By Max Byerly]

    Rite Aid Co. (NYSE:RAD) dropped 6% during trading on Wednesday . The company traded as low as $1.88 and last traded at $1.89. Approximately 11,889,301 shares traded hands during trading, a decline of 37% from the average daily volume of 18,730,842 shares. The stock had previously closed at $2.01.

  • [By Keith Speights]

    Shares of major pharmacy chains CVS Health Corp. (NYSE:CVS), Rite Aid Corporation (NYSE:RAD), and Walgreens Boots Alliance Inc. (NASDAQ:WBA) sank by 9% or more as of 11:07 a.m. EDT on Thursday. All three stocks were impacted by the same big news: Amazon’s (NASDAQ:AMZN) acquisition of PillPack.

  • [By Max Byerly]

    Glen Harbor Capital Management LLC purchased a new position in shares of Rite Aid Co. (NYSE:RAD) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 220,096 shares of the company’s stock, valued at approximately $370,000.

Top 10 Performing Stocks To Buy For 2019: Bank of Nova Scotia (BNS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) has earned an average rating of “Hold” from the eleven ratings firms that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $94.00.

  • [By Shane Hupp]

    Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is C$88.62.

  • [By Motley Fool Staff]

    Bank of Nova Scotia (NYSE:BNS)Q2 2018 Earnings Conference CallMay 29, 2018, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Adam Borgatti — Vice President, Investor Relations

  • [By Stephan Byrd]

    Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) insider Andrew Branion sold 332 shares of the firm’s stock in a transaction on Wednesday, October 10th. The shares were sold at an average price of C$74.49, for a total value of C$24,730.68.

Hot Blue Chip Stocks For 2019

&l;p&g;&l;img class=&q;dam-image bloomberg wp-image-34305176 size-large&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/34305176/960×0.jpg?fit=scale&q; alt=&q;&q; data-height=&q;560&q; data-width=&q;960&q;&g; Photo: Simon Dawson/Bloomberg.

Want to snap up some FTSE 100 stocks but are short on cash? Then check out the blue chip winners I&a;rsquo;ve identified below.

&l;strong&g;Taylor Wimpey&l;/strong&g;

Housebuilder Taylor Wimpey is slated to release half-year results on Tuesday, July 31. I&a;rsquo;m expecting another solid update and so I&a;rsquo;m tempted to snap up some more of the stock that I already own.

Last time out in April the business advised that &a;ldquo;&l;em&g;the underlying housing market has remained stable in the first four months of 2018, with continued good accessibility to mortgages at competitive rates&l;/em&g;.&a;rdquo; Conditions in London are becoming more difficult as the challenging political and economic landscape weighs, although in respect of the broader housing market conditions remain strong thanks to those supportive lending conditions and the country&a;rsquo;s woefully-inadequate housing stock.

Hot Blue Chip Stocks For 2019: Halyard Health, Inc.(HYH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Halyard Health (NYSE:HYH) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.26.

  • [By Logan Wallace]

    Renaissance Technologies LLC acquired a new position in Halyard Health (NYSE:HYH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 9,805 shares of the medical instruments supplier’s stock, valued at approximately $453,000.

Hot Blue Chip Stocks For 2019: Charter Financial Corp.(CHFN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

  • [By Logan Wallace]

    Charter Financial (NASDAQ: CHFN) and Provident Financial (NASDAQ:PROV) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Hot Blue Chip Stocks For 2019: Coca-Cola Company (KO)

Advisors’ Opinion:

  • [By ]

    What I like here is the fact that 3G is actively searching for acquisitions for Heinz to help settle the debt. Recently, an attempt was made to acquire Unilever, and I fully expect these acquisition forays to continue until a suitable target is captured. Some analysts have gone as far to say that monster Coca-Cola (NYSE: KO) may be being seriously considered!

  • [By Neha Chamaria]

    The first list of Dividend Aristocrats published in 1989 comprised 26 stocks. Remarkably, nine of the 26 stocks are still part of the Dividend Aristocrat group.

    Dividend Aristocrat No. of Years of Consecutive Dividend Increases Payout Ratio (Last 12 Months) Current Dividend Yield
    Colgate-Palmolive Company (NYSE: CL) 55 67.6% 2.7%
    Dover Corp. (NYSE: DOV) 62 37.4% 2%
    Emerson Electric(NYSE: EMR) 60 69% 2.62%
    Genuine Parts Company(NYSE: GPC) 62 62.7% 3.12%
    Johnson & Johnson(NYSE: JNJ) 55 724.9% 2.57%
    Coca-Cola(NYSE: KO) 55 440.7% 3.5%
    Lowe’s Companies(NYSE: LOW) 55 37.4% 1.97%
    3M Company(NYSE: MMM) 60 70.4% 2.65%
    Procter & Gamble(NYSE: PG) 62 72.2% 3.94%

    Data source: S&P Global Market Intelligence, company financials, Yahoo Finance. Table by author.

  • [By ]

    What do companies like Coca-Cola (NYSE: KO), Campbell’s Soup (NYSE: CPB) and Deere & Co. (NYSE: DE) all have in common?

    You might think not much. But think for a moment about some of the absolute chaos that has happened in the 20th century, not to mention this nascent 21st. There was World War I, World War II, Vietnam, etc. You had the Great Depression, the Oil embargo, the tech bubble, the global financial crisis… There were pandemics, assassinations, terror attacks the list goes on.

  • [By Chris Hill]

    Coca-Cola (NYSE:KO) is testing out some new drinks in Japan, with varying levels of alcohol. In today’s episode of Market Foolery, host Chris Hill and Motley Fool contributor Jason Moser talk about the beverage industry and what Coca-Cola is probably looking to gain from this experiment.

  • [By ]

    YouTube’s ad-related headaches began in March 2017 when a group of brands including Coca-Cola, (KO) Walmart (WMT)  and AT&T (T) left the platform due to ads showing up next to offensive content. Giant advertiser Procter and Gamble (PG)  only returned to advertising on YouTube last month on a more limited basis.

Hot Blue Chip Stocks For 2019: Meredith Corporation(MDP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Gabelli Funds LLC increased its holdings in shares of Meredith Co. (NYSE:MDP) by 1.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 211,200 shares of the company’s stock after buying an additional 2,000 shares during the quarter. Gabelli Funds LLC owned 0.47% of Meredith worth $11,363,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Meredith (MDP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Meredith Co. (NYSE:MDP) declared a quarterly dividend on Wednesday, May 9th, RTT News reports. Investors of record on Thursday, May 31st will be given a dividend of 0.545 per share on Friday, June 15th. This represents a $2.18 annualized dividend and a dividend yield of 4.25%.

Top 10 Low Price Stocks To Invest In Right Now

Either low-income Americans became rich this Black Friday, or Wal-Mart’s (NYSE:WMT) marketers do not know what they are doing.

For years, $133,653 Cartier watches and expensive jewelry were sold in upper scale stores, where high income Americans prefer to shop on Black Friday. 

This year, Cartier watches are being sold on the Walmart.com site.

But who will buy them? Will high income Americans trade the upscale store for Wal-Mart’s site? That sounds very unlikely to me. Shopping for luxury items is usually more about the experience of shopping rather than about price.

What about Wal-Mart’s low-income shoppers? That’s unlikely, too, as they cannot afford items that sell at a hefty multiple of their annual income. Besides, some of Wal-Mart’s shoppers do not even use credit cards, so how can they purchase $133,653 watches on-line?

For more than three decades, Wal-Mart ruled the US retailing industry. Its large stores and everyday low prices were too much for smaller neighborhood stores and supermarkets. Result? They went out of business shortly after Wal-Mart invaded their turf.

Top 10 Low Price Stocks To Invest In Right Now: Yanzhou Coal Mining Company Limited(YZC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, energy shares slipped by just 0.1 percent. Meanwhile, top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), and Yanzhou Coal Mining Co Ltd (ADR) (NYSE: YZC).

Top 10 Low Price Stocks To Invest In Right Now: VivoPower International PLC (VVPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Twin Disc, Incorporated (NASDAQ: TWIN) shares surged 24.34 percent to close at $28.86 following Q3 earnings.
    Bioblast Pharma Ltd. (NASDAQ: ORPN) rose 21.89 percent to close at $2.45.
    Evolus, Inc. (NASDAQ: EOLS) gained 20.19 percent to close at $8.75. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) rose 18.56 percent to close at $3.13 on Monday after falling 39.86 percent on Friday.
    CEL-SCI Corporation (NYSE: CVM) gained 17.09 percent to close at $2.74.
    athenahealth, Inc. (NASDAQ: ATHN) shares jumped 16.39 percent to close at $146.75 on Monday after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Gramercy Property Trust (NYSE: GPT) rose 15.45 percent to close at $27.50 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 15.23 percent to close at $6.43 after the company posted upbeat quarterly profit.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 14.53 percent to close at $7.33
    CohBar, Inc. (NASDAQ: CWBR) gained 14.36 percent to close at $6.29.
    Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) gained 12.69 percent to close at $3.64.
    Gannett Co., Inc. (NYSE: GCI) gained 12.27 percent to close at $10.89 following Q1 results.
    CVR Refining, LP (NYSE: CVRR) shares climbed 9.8 percent to close at $19.05.
    Illumina, Inc. (NASDAQ: ILMN) rose 4.93 percent to close at $256.89. Barclays upgraded Illumina from Equal-Weight to Overweight.
    Cloudera, Inc. (NYSE: CLDR) surged 3.92 percent to close at $15.63. Craig-Hallum initiated coverage on Cloudera with a Buy rating.

     

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By Lisa Levin] Gainers
    athenahealth, Inc. (NASDAQ: ATHN) shares climbed 23.2 percent to $155.19 after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Evolus, Inc. (NASDAQ: EOLS) gained 21.3 percent to $8.83. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) climbed 18.2 percent to $3.12 after falling 39.86 percent on Friday.
    Gramercy Property Trust (NYSE: GPT) rose 15.6 percent to $27.53 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    EP Energy Corporation (NYSE: EPE) rose 13 percent to $2.26.
    Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) gained 11.9 percent to $7.35.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 11.8 percent to $6.24 after the company posted upbeat quarterly profit.
    Sanchez Energy Corporation (NYSE: SN) shares gained 11.3 percent to $3.56.
    CVR Refining, LP (NYSE: CVRR) shares rose 8.8 percent to $18.875.
    Monaker Group, Inc. (NASDAQ: MKGI) rose 8.7 percent to $2.9683.
    Kosmos Energy Ltd. (NYSE: KOS) shares rose 7.4 percent to $7.40.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 7 percent to $2.88 after climbing 1.89 percent on Friday.
    Cloudera, Inc. (NYSE: CLDR) surged 6 percent to $15.93. Craig-Hallum initiated coverage on Cloudera with a Buy rating.
    Illumina, Inc. (NASDAQ: ILMN) rose 5.1 percent to $257.35. Barclays upgraded Illumina from Equal-Weight to Overweight.

    Check out these big penny stock gainers and losers

  • [By Money Morning News Team]

    Just look at VivoPower International Plc. (Nasdaq: VVPR), the penny stock that topped our list of the 10 top penny stocks to watch this week.

Top 10 Low Price Stocks To Invest In Right Now: OncoSec Medical Incorporated(ONCS)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

Top 10 Low Price Stocks To Invest In Right Now: Umicore S.A. (UMICF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other major cobalt miners (note their focus is mostly on copper and nickel or other commodities) include Eurasian Resources Group (private), Umicore SA (OTCPK:UMICF), Lundin Mining (TSX:LUN) (OTCPK:LUNMF), MMC Norilsk Nickel (OTCPK:NILSY) (LSX:MNOD), Vale S.A. (NYSE:VALE), BHP (NYSE:BHP), Jinchuan Group International Resources Co Ltd (HK:2362).

Top 10 Low Price Stocks To Invest In Right Now: The Middleby Corporation(MIDD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Middleby (NASDAQ: MIDD) and Tennant (NYSE:TNC) are both industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Anheuser-Busch InBev SA/NV (NYSE: BUD) is estimated to report quarterly earnings at $0.89 per share on revenue of $13.06 billion.
    SINA Corporation (NASDAQ: SINA) is expected to report quarterly earnings at $0.42 per share on revenue of $433.32 million.
    Weibo Corporation (NASDAQ: WB) is projected to report quarterly earnings at $0.47 per share on revenue of $342.39 million.
    Ameren Corporation (NYSE: AEE) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.55 billion.
    Mylan N.V. (NASDAQ: MYL) is projected to report quarterly earnings at $0.98 per share on revenue of $2.75 billion.
    Cinemark Holdings, Inc. (NYSE: CNK) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.51 billion.
    ADT Inc. (NYSE: ADT) is expected to report quarterly earnings at $0.24 per share on revenue of $1.11 billion.
    Coty Inc. (NYSE: COTY) is projected to report quarterly earnings at $0.13 per share on revenue of $2.18 billion.
    Pinnacle Entertainment, Inc. (NYSE: PNK) is estimated to report quarterly earnings at $0.31 per share on revenue of $644.94 million.
    Conduent Incorporated (NYSE: CNDT) is estimated to report quarterly earnings at $0.21 per share on revenue of $1.44 billion.
    Delphi Technologies PLC (NYSE: DLPH) is projected to report quarterly earnings at $1.16 per share on revenue of $1.25 billion.
    Office Depot, Inc. (NASDAQ: ODP) is expected to report quarterly earnings at $0.08 per share on revenue of $2.72 billion.
    Global Partners LP (NYSE: GLP) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.33 billion.
    Wolverine World Wide, Inc. (NYSE: WWW) is projected to report quarterly earnings at $0.37 per share on revenue of $530.99 million.
    Performance Food Group Company (NYSE: PFGC) is expected to report quarterly earnings at $0.32 per share on revenue of $4.46 billion.
    Groupon, Inc. (NASDAQ: GRPN) is projected to report
  • [By Rich Smith]

    History repeated itself. For the second earnings quarter in a row, shares of commercial oven-maker Middleby (NASDAQ:MIDD)are down 13.7% as of 11 a.m. EDT after the company reported Q1 sales and earnings that fell short of Wall Street estimates.

  • [By Dan Caplinger]

    Wednesday was a strong day on Wall Street, and major benchmarks posted solid gains of around 1%. Market participants were generally happy about oil prices moving back into the $70s, hoping for a rebound in hard-hit areas of the country that had taken advantage of the triple-digit oil prices of the early 2010s by dramatically ramping up production of shale plays and similar opportunities. Yet even with the generally favorable mood, some stocks weren’t able to join the rally. Kinross Gold (NYSE:KGC), Weibo (NASDAQ:WB), and Middleby (NASDAQ:MIDD) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Low Price Stocks To Invest In Right Now: Halyard Health, Inc.(HYH)

Advisors’ Opinion:

  • [By Nelson Hem]

    Medical products maker Halyard Health Inc (NYSE: HYH) stumbled after its spinoff from paper products giant Kimberly Clark Corp (NYSE: KMB), according to “Halyard Health Shares Look Poised to Double” by David Englander. See why Barron’s thinks its shares could double as this Georgia-based company pursues acquisitions and expands its product lineup.

  • [By Nelson Hem]

    See what Barron’s feels are the prospects for Ingersoll-Rand PLC (NYSE: IR) despite the woes in energy, Michael Kors Holdings Ltd (NYSE: KORS) with its new products and international expansion, the Valvoline spinoff from Ashland Inc (NYSE: ASH), as well as Halyard Health Inc (NYSE: HYH) as it pursues acquisitions and expands its product lineup.

  • [By Shane Hupp]

    Halyard Health (NYSE:HYH) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.26.

Top 10 Low Price Stocks To Invest In Right Now: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) dropped about 12.3% Wednesday to post a new 52-week low of $12.93 after closing at $14.74 on Tuesday. The stock’s 52-week high is $19.62. Volume of around 2.8 million was nearly 5 times the daily average. The company had no specific news.

  • [By Shane Hupp]

    Lexicon Pharmaceuticals (NASDAQ:LXRX) – Analysts at Wedbush issued their Q1 2019 earnings per share (EPS) estimates for Lexicon Pharmaceuticals in a note issued to investors on Monday, May 7th. Wedbush analyst L. Moussatos expects that the biopharmaceutical company will earn ($0.28) per share for the quarter. Wedbush currently has a “Outperform” rating and a $40.00 target price on the stock. Wedbush also issued estimates for Lexicon Pharmaceuticals’ Q2 2019 earnings at ($0.25) EPS, Q3 2019 earnings at ($0.13) EPS, Q4 2019 earnings at ($0.06) EPS, FY2020 earnings at $0.53 EPS, FY2021 earnings at $2.22 EPS and FY2022 earnings at $3.81 EPS.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Invest In Right Now: Federal-Mogul Holdings Corporation(FDML)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Mario Gabelli on Monday gained the upper hand in his battle to force Carl Icahn to sweeten his offer for a car-parts manufacturer. Icahn, who owns 82 percent of Federal-Mogul (NASDAQ: FDML), offered $9.25 a share for the remaining stake but fell way short after Gamco Investors boss Gabelli — who has a leading stake in Federal-Mogul — pressed for a higher price.

Top 10 Low Price Stocks To Invest In Right Now: PAREXEL International Corporation(PRXL)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a news impact score of 0.18 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 49.4978250148766 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Low Price Stocks To Invest In Right Now: Houghton Mifflin Harcourt Company(HMHC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Barnes & Noble Education and global learning stockHoughton Mifflin Harcourt Co (NASDAQ: HMHC)underperforming while Barnes & Noble is back to breakeven levels and textbook stock Chegg Inc (NYSE: CHGG) has taken off:

  • [By Peter Graham]

    A long term performance chart shows Chegg Inc finallymovingabove IPO levels while potential performance benchmarks such as Houghton Mifflin Harcourt Co (NASDAQ: HMHC) and Barnes & Noble Education Inc (NYSE: BNED), a spin off from Barnes & Noble, Inc (NYSE: BKS), have seen their performance slip:

Halyard Health (HYH) Issues FY18 Earnings Guidance

Halyard Health (NYSE:HYH) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.26.

A number of brokerages have commented on HYH. Zacks Investment Research raised shares of Halyard Health from a sell rating to a hold rating in a research note on Friday. Morgan Stanley lifted their price target on shares of Halyard Health from $48.50 to $52.00 and gave the stock an underweight rating in a research note on Thursday. Deutsche Bank lifted their price target on shares of Halyard Health from $42.00 to $50.00 and gave the stock a buy rating in a research note on Thursday. Stifel Nicolaus lifted their price target on shares of Halyard Health from $52.00 to $58.00 and gave the stock a buy rating in a research note on Thursday. Finally, KeyCorp lifted their price target on shares of Halyard Health from $61.00 to $62.00 and gave the stock an overweight rating in a research note on Thursday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of Buy and a consensus price target of $55.20.

Get Halyard Health alerts:

HYH stock opened at $52.10 on Friday. Halyard Health has a 12 month low of $35.24 and a 12 month high of $54.09. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.22 and a quick ratio of 2.74. The stock has a market cap of $2,434.21, a P/E ratio of 19.95, a PEG ratio of 3.33 and a beta of 1.62.

Halyard Health (NYSE:HYH) last released its quarterly earnings results on Wednesday, May 2nd. The medical instruments supplier reported $0.76 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.59. Halyard Health had a net margin of 7.72% and a return on equity of 7.90%. The firm had revenue of $156.40 million during the quarter, compared to analysts’ expectations of $155.08 million. During the same period in the previous year, the company earned $0.48 EPS. The firm’s revenue for the quarter was up 7.3% compared to the same quarter last year. research analysts expect that Halyard Health will post 1.75 earnings per share for the current year.

Halyard Health Company Profile

Halyard Health, Inc operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management.

Top High Tech Stocks To Own For 2018

Piper’s Teen Survey Gives Possible Insight Into Future of Tech

Piper Jaffray’s out with its latest survey that it takes among 10,000 teenagers. The concept is to get a better feel for what young people like, ranging from favorite handbag brands to top restaurants and (importantly for Eye on Tech) their favorite social media platforms.

Perhaps with little surprise, Snap (Private:CHAT) garnered the top result, with 35% of the vote. coming in behind Snapchat is Facebook’s (NASDAQ:FB) Instagram, with just 24% of the votes. It wasn’t that long ago that Instagram was the top dog on the list and in the spring finally conceded its grip atop the Iron Throne.

Engagement at Instagram is up – which is good for Facebook – but engagement for its own platform is down among teens. Perhaps with Instagram copying some of Snapchat’s biggest features and the subsequent growth that has followed will help buoy the social media platform.

But the latest results could draw at least a little bit of concern considering that Snapchat continues to gobble up market share as the most preferred platform.

Top High Tech Stocks To Own For 2018: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Chris Lange]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By Lisa Levin]

    Shares of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) got a boost, shooting up 32 percent to $12.40 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.

Top High Tech Stocks To Own For 2018: Snyder's-Lance, Inc.(LNCE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Snyder’s-Lance Inc (NASDAQ: LNCE) is estimated to report its quarterly earnings at $0.23 per share on revenue of $470.33 million.

    Examworks Group, Inc. (NYSE: EXAM) is projected to post its quarterly earnings at $0.08 per share on revenue of $217.47 million.

Top High Tech Stocks To Own For 2018: (VIAB)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    This morning, President Trump suggested that the United States is considering strong military action in response to recent chemical attacks carried out on civilians by the Syrian government. The president promised to send “nice and new and ‘smart'” missiles to Syria and accused the Russian government of partnering with a “Gas Killing Animal who kills his people and enjoys it!” The president’s remarks are a significant departure from comments made last week, which suggested that the United States would be pulling out of Syria in the coming months. Trump’s threat of war over a recent chemical attack in Syria drove crude oil and gold prices higher. Geopolitical worries often offer a boost to commodity prices due to concerns about supply. Trump’s threat comes at a time that markets are already concerned about a significant military conflict in the Middle East between Saudi Arabia and Iran. WTI crude prices added 0.9% to hit $66.10 per barrel. Brent crude pushed to $71.10 per barrel. Gold price topped $1,350 per ounce and are poised for bigger gains. According to Axios, U.S. Speaker of the House Paul Ryan (R-WI) has privately told friends that he will not seek reelection in the fall. The news comes at a perilous time for Republicans, who are expected to lose the House of Representatives and potentially the Senate. Axios was the first to report the news. The story is also notable because Ryan recently achieved his long-time goal of passing tax reform in late 2017.
    Four Stocks to Watch Today: FB, FOXA, CBS
    Shares of Twenty-First Century Fox Inc.(NYSE: FOXA) fell in pre-market hours on news that investigators from the European Commission raided the firm’s London office yesterday. Reports indicate that investigators are trying to keep their goals confidential. However, there has been a lot of scrutiny over Rupert Murdoch’s goal to purchase rival Sky in recent months. British authorities have argued that this deal would not be in the public’s best interest. Accor

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

  • [By WWW.THESTREET.COM]

    Viacom (VIAB) CEO Bob Bakish wants to make a clean break with a sluggish past.

    In a mover that follows a reorganization of Viacom’s cable TV network group, Bakish on Wednesday announced that Brad Grey will leave Paramount Pictures after 12 years atop the Hollywood studio.

  • [By Douglas A. McIntyre]

    CBS Corp. (NYSE: CBS) may make a low-ball bid to buy Viacom Inc. (NASDAQ: VIAB). According to Bloomberg:

    CBS Corp. will offer less than the current market value of Viacom Inc. in its opening bid for the owner of MTV and Nickelodeon, according to a person with knowledge of the matter, showing how far apart the companies are as they explore recombining.

  • [By Lisa Levin]

    U.S. stock futures traded higher in early pre-market trade, ahead of earnings from Wal-Mart Stores Inc (NYSE: WMT), Viacom, Inc. (NASDAQ: VIAB) and Best Buy Co Inc (NYSE: BBY). Data on initial jobless claims for the latest week, the Philly Fed manufacturing index for November and data on import prices for October will be released at 8:30 a.m. ET. Data on industrial production for October will be released at 9:15 a.m. ET, while the housing market index for November is schedule for release at 10:00 a.m. ET. Cleveland Federal Reserve Bank President Loretta Mester is set to speak in Washington at 9:10 a.m. ET, while Dallas Federal Reserve Bank President Robert Kaplan will speak in Houston at 1:10 p.m. ET. Federal Reserve Governor Lael Brainard is set to speak in Ann Arbor, Michigan at 3:45 p.m. ET.

Top High Tech Stocks To Own For 2018: Halyard Health, Inc.(HYH)

Advisors’ Opinion:

  • [By Nelson Hem]

    See what Barron’s feels are the prospects for Ingersoll-Rand PLC (NYSE: IR) despite the woes in energy, Michael Kors Holdings Ltd (NYSE: KORS) with its new products and international expansion, the Valvoline spinoff from Ashland Inc (NYSE: ASH), as well as Halyard Health Inc (NYSE: HYH) as it pursues acquisitions and expands its product lineup.

  • [By Nelson Hem]

    Medical products maker Halyard Health Inc (NYSE: HYH) stumbled after its spinoff from paper products giant Kimberly Clark Corp (NYSE: KMB), according to “Halyard Health Shares Look Poised to Double” by David Englander. See why Barron’s thinks its shares could double as this Georgia-based company pursues acquisitions and expands its product lineup.